FDA In Brief: FDA warns patients and health care professionals about rare instances of serious liver injury or failure with certain hepatitis C treatments in some patients with advanced liver disease - PRNewswire

FDA In Brief: FDA warns patients and health care professionals about rare instances of serious liver injury or failure with certain hepatitis C treatments in some patients with advanced liver disease  PRNewswire

SILVER SPRING, Md., Aug. 28, 2019 /PRNewswire/ -- "Hepatitis C virus remains a significant public health issue, but effective therapeutic options have helped ...